Skip to main content
ConductScienceScienceDex

Xiaoyan Li

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #37,248
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 80239906Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2026 onlyCareer claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$400K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#37,248
By linked amount among FY2026 PIs
Earliest Year Loaded
2026
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Xiaoyan Li. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$400K

1 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award data coverage

ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.

Single fiscal year on record (FY2026): $400K in linked award amounts across 1 award record · Award-linked rank #37248.

FY2026 award records by amount

NIH award records listing Xiaoyan Li as a PI. Multi-PI records show the full award amount for context.

  • 1R43CA310454-01A1R43Contact PI
    Study of CB-101: A Novel First-in-Class Trispecific Antibody Targeting ROR1, EpCAM, and CD3 for the Treatment of Colorectal Cancer and Other Solid Tumors
    Xtop Biotherapeutics Inc.
    $400K
    award amount

Award organization

Organizations that administered FY2026 awards listing Xiaoyan Li as a PI.

FY2026 award administered by Xtop Biotherapeutics Inc. (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2026
    First NIH Award
    Xtop Biotherapeutics Inc.

Explore further

Find collaborators for Xiaoyan Li

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →